A federal judge denied a bid to stall the implementation of Purdue Pharma’s bankruptcy plan; Social Security checks are expected to increase in 2022; the FDA has released guidelines for the food industry aimed at lowering sodium levels.
A federal judge in New York denied the US Justice Department's bid to halt the implementation of a controversial bankruptcy plan for Purdue Pharma, the maker of Oxycontin (oxycodone), as reported by NPR. During a hearing earlier this week, Judge Colleen McMahon expressed support for the pause until the deal could be reviewed, citing significant legal concerns regarding the settlement that warrant a review by the Second Circuit Court of Appeals. However, her new ruling also says that work on the settlement, valued between $5 billion $10 billion, can go forward. In addition, she ordered supporters of the plan to enter written agreements that they will not attempt to block an appeal using the equitable mootness argument.
The Social Security Administration has announced that recipients will receive almost a 6% increase in benefits in 2022. According to NBC News, the boost will affect nearly 70 million people and is fueled by a spike in inflation caused by supply chain bottlenecks, worker shortages, and other economic disruptions that emerged as a result of the COVID-19 pandemic. Recently published data from the Bureau of Labor Statistics showed that prices rose by 5.4% on an annualized basis in September 2021 and the inflation rate rose a seasonally adjusted 0.4% in September, from August 2021. The government said that beneficiaries should receive a notice detailing their increased payments for 2022 in December 2021.
A report from The Associated Press says that the FDA updated its guidelines for the food industry, with the aim of lowering sodium levels in dozens of foods, including condiments, cereals, french fries, and potato chips. The voluntary goals for 163 food categories are projected to help lower the amount of salt that people eat, which mostly comes from packaged or restaurant foods, making it difficult for people to make changes on their own. To ensure that people get used to lower sodium intakes, the FDA said the reductions should be gradual and across the entire food supply, so people don’t keep reaching for higher-sodium options. The FDA’s target is to cut the average sodium intake by 12%, reducing consumption from 3400 to 3000 mg/day, over the next 2.5 years.
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
Urticaria Diagnosis Challenged by Overlapping Pruritic Skin Conditions
April 23rd 2025Urticaria is complicated to diagnose by its symptomatic overlap with other skin conditions and the frequent misclassification in literature of distinct pathologies like vasculitic urticaria and bullous pemphigus.
Read More
New Research Challenges Assumptions About Hospital-Physician Integration, Medicare Patient Mix
April 22nd 2025On this episode of Managed Care Cast, Brady Post, PhD, lead author of a study published in the April 2025 issue of The American Journal of Managed Care®, challenges the claim that hospital-employed physicians serve a more complex patient mix.
Listen
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
ACOs’ Focus on Rooting Out Fraud Aligns With CMS Vision Under Oz
April 23rd 2025Accountable care organizations (ACOs) are increasingly playing the role of data sleuths as they identify and report trends of anomalous billing in hopes of salvaging their shared savings. This mission dovetails with that of CMS, which under the new administration plans to prioritize rooting out fraud, waste, and abuse.
Read More
2 Commerce Drive
Cranbury, NJ 08512